IL4 and pancreatic neoplasm: Previous mouse models have shown that, by targeting Interleukin-4, an inhibitory cytokine expressed by the TME in pancreatic cancer, next generation anti-PSCA CAR T-cells were able to eliminate tumor cells [98].